Ikaria, Inc.Clinton, NJ United States
Company Description
Ikaria does its best to care for the most vulnerable among us. The vertically integrated company performs R&D, manufacturing, and sales and marketing in pursuit of easier breathing for critically ill infants. Its INOtherapy system includes the drug INOMAX (inhaled nitric oxide), delivery mechanism, and support services sold in North America as well as in Australia and Japan. The system works with existing ventilators and anesthesia machines to ease the symptoms of hypoxic respiratory failure, which causes lung blood vessels to constrict. Ikaria is pursuing additional approvals for INOMAX and has several other critical care drugs in its pipeline. Formed in 2006, the company filed to go public in 2010.
| 6 State Rte. 173 | Phone: 908-238-6600 | http://www.ikaria.com |
| Clinton, NJ 08809 | Fax: 908-238-6633 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Ikaria, Inc. Rankings
Executives
| 24 executives listed for Ikaria, Inc.'s Clinton, NJ location. | ||
| Chairman, President, and CEO | Daniel Tassé | |
|---|---|---|
| CFO | Craig Tooman | |
| Chief Medical Officer | Geoffrey Nichol | |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Ikaria, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
